Association Between Tumor Progression Endpoints and Overall Survival in Patients with Advanced Neuroendocrine Tumors

Endpoints related to tumor progression are commonly used in clinical trials of novel therapeutic agents for neuroendocrine tumors (NETs). Whether improved tumor control translates into improved overall survival (OS), however, is uncertain. We assessed associations between tumor progression endpoints...

Descripción completa

Detalles Bibliográficos
Autores principales: Ter‐Minassian, Monica, Zhang, Sui, Brooks, Nichole V., Brais, Lauren K., Chan, Jennifer A., Christiani, David C., Lin, Xihong, Gabriel, Sylvie, Dinet, Jérôme, Kulke, Matthew H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AlphaMed Press 2017
Materias:
Gastrointestinal Cancer
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5330705/
https://www.ncbi.nlm.nih.gov/pubmed/28179574
http://dx.doi.org/10.1634/theoncologist.2016-0175

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5330705/
https://www.ncbi.nlm.nih.gov/pubmed/28179574
http://dx.doi.org/10.1634/theoncologist.2016-0175

Ejemplares similares